Vardenafil (Levitra/Staxyn) Compounding Legal Status
Current FDA regulatory status of vardenafil compounding, including patent history, 503A/503B pharmacy rules, and what patients need to know about compounded vardenafil legality and safety.
Vardenafil: Regulatory History
3 source-based articles maintained by the HealthRX.com Editorial Team.
3articles
2topic areas covered
May 26, 2026latest review
Vardenafil: Regulatory History library
Showing 3 of 3 clinical reviews.
Vardenafil (Levitra/Staxyn) FAERS Safety Signals: What the Post-Market Data Show
A comprehensive review of vardenafil FAERS adverse-event reports, FDA label warnings, post-market surveillance data, and clinical trial safety findings for Levitra and Staxyn.
Vardenafil (Levitra/Staxyn) FDA Approval History
Complete FDA approval timeline for vardenafil, including Levitra film-coated tablets (2003), Staxyn ODT (2010), generic entry, label updates, and post-market safety data.
